Status:
COMPLETED
Asthma Control in a Dutch Primary Care Population
Lead Sponsor:
General Practitioners Research Institute
Collaborating Sponsors:
AstraZeneca
Conditions:
Asthma
Asthma; Eosinophilic
Eligibility:
All Genders
18+ years
Brief Summary
Rationale: Despite the availability of effective treatment to reach symptom control, nearly half of the asthma patients remain inadequately controlled. There is a need for timely and appropriate treat...
Eligibility Criteria
Inclusion
- Aged ≥ 18 years
- Physician diagnosis of Asthma
- Capacity to provide written informed consent
Exclusion
- Life expectancy of less than 1 year
- Inability to understand Dutch
- Any other condition which, at the GPs and/or investigator's discretion, is believed to present a safety risk or may impact the study results
- Patients participating in a clinical trial that may distort outcomes in this observational study.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
222 Patients enrolled
Trial Details
Trial ID
NCT04456270
Start Date
October 1 2020
End Date
March 1 2022
Last Update
May 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GPRI
Groningen, Netherlands